共 86 条
[1]
Duffy MJ(2002)Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies Clin Chem 48 1194-1197
[2]
Andreasen PA(1997)The urokinase-type plasminogen activator system in cancer metastasis: a review Int J Cancer 72 1-22
[3]
Kjoller L(2001)Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells J Cell Sci 114 3387-3396
[4]
Christensen L(1999)Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system Thromb Haemost 82 298-304
[5]
Duffy MJ(1998)Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization Nat Med 4 923-928
[6]
Ma Z(2001)The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies J Cell Biol 152 777-784
[7]
Webb DJ(2002)Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients J Natl Cancer Inst 94 116-128
[8]
Jo M(2003)Association of uPA, PAT-1, and uPAR in nipple aspirate fluid (NAF) with breast cancer Cancer J 9 293-301
[9]
Gonias SL(2010)Carbohydrate antigens in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy BMC Cancer 10 519-1206
[10]
Blasi F(1984)T and Tn, general carcinoma autoantigens Science 224 1198-501